| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
Regulatory Affairs: Part I: The IND Phase, Part II: The CTD/NDA Phase | |
| |
April 23, 2008 |
|
|
| |
|
|
| |
|
|
|
Drug Information Association, Massachusetts College of Pharmacy, Boston, MA, USA
Aug 4 2008
This course combines the two three-day courses into one extended five-day offering. It describes the regulatory background of the IND and NDA and provides an overview of the requirements and recommendations for preparing and managing these applications. Please note that this August offering is a 5 day version of Regulatory Affairs: Part I: The IND Phase and Part II: The CTD/NDA Phase.
|
|
|
|
|
|
|
|
Organized by:
|
|
Drug Information Association |
|
|
Invited Speakers:
|
|
1) Roger W CroswellPresidentRegulatory Consulting Services, LLC United States. 2) Michael R. Hamrell, PhD, RAC President MORIAH ConsultantsUnited States. 3) Drusilla L. Scott, PhD, RACVP, Regulatory AffairsCempra PharmaceuticalsUnited States.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=16065&eventType=Training%20Course
|
|
|
E-mail:
|
|
dia@diahome.org
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|